Endoscopic resection of early esophageal neoplasia in patients with esophageal varices: a systematic review
Endoscopy · 01.07.2025 · 57 (07) · 769-777
DOI: 10.1055/a-2524-4148 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Endoscopy, erschienen am 01.07.2025. Verfasst von Charlotte N Frederiks und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, St. Antonius Hospital, Nieuwegein, Netherlands. Hauptthemen laut MEDLINE: Esophageal and Gastric Varices, Esophageal Neoplasms, Gastrointestinal Hemorrhage, Esophagoscopy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Although endoscopic resection (ER) is recommended as first-choice treatment for early esophageal neoplasia, patients with esophageal varices are considered a high-risk group owing to an increased risk of bleeding. This systematic review aimed to evaluate the effectiveness and safety of ER in this specific patient category. We searched for studies reporting on clinical outcomes of ER in the presence of esophageal varices, irrespective of study design or follow-up time. End points included the incidence of prophylactic measures to reduce the risk of variceal hemorrhage, radical and curative resection rates, and adverse events. After screening 2371 studies, 42 studies (including our own unpublished cohort) with a total of 186 patients were included in this systematic review. Endoscopic band ligation (72/186; 39%) and endoscopic injection sclerotherapy (22/186; 12%) were the prophylactic measures most widely adopted to eradicate varices prior to ER. Other frequently described prophylactic measures included direct varix coagulation during ER (18/186; 10%) and the placement of a transjugular intrahepatic portosystemic shunt prior to ER (9/186; 5%). While the radical and curative resection rates were high (86% and 72%, respectively), the periprocedural and delayed bleeding risks were reported to be relatively low (6% and 3%, respectively). In all studies, no procedure-related mortality was observed. ER appeared to be a safe and effective treatment option in selected patients with concurrent early esophageal neoplasia and esophageal varices, provided that a tailored approach of adequate prophylactic measures to prevent bleeding is applied.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, St. Antonius Hospital, Nieuwegein, Netherlands.
- Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
- Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, Amsterdam Gastroenterology Endocrinology and Metabolism, Cancer Center Amsterdam, Amsterdam, Netherlands.
ORCID-Profile: Charlotte N Frederiks, Bas L A M Weusten
Zitieren
APA
Frederiks, C. N., Boer, L. S., Gloudemans, B., Alvarez Herrero, L., Bergman, J. J. G. H. M., Pouw, R. E., & Weusten, B. L. A. M. (2025). Endoscopic resection of early esophageal neoplasia in patients with esophageal varices: a systematic review. Endoscopy, 57(07), 769-777. https://doi.org/10.1055/a-2524-4148
Vancouver
Frederiks CN, Boer LS, Gloudemans B, Alvarez Herrero L, Bergman JJGHM, Pouw RE, et al. Endoscopic resection of early esophageal neoplasia in patients with esophageal varices: a systematic review. Endoscopy. 2025;57(07):769-777. doi:10.1055/a-2524-4148
BibTeX
@article{Frederiks2025,
author = {Frederiks, Charlotte N and Boer, Laura S and Gloudemans, Bas and Alvarez Herrero, Lorenza and Bergman, Jacques J G H M and Pouw, Roos E and Weusten, Bas L A M},
title = {Endoscopic resection of early esophageal neoplasia in patients with esophageal varices: a systematic review},
journal = {Endoscopy},
year = {2025},
volume = {57},
number = {07},
pages = {769--777},
doi = {10.1055/a-2524-4148}
}
EUVIMED